Inactivation of the invasion inhibitory gene IIp45 by alternative splicing in gliomas.
暂无分享,去创建一个
Wei Zhang | Wei Zhang | G. Fuller | S. Song | Gregory N Fuller | Hong Zheng | Sonya W Song | Hong Zheng
[1] I. Shmulevich,et al. Computational and Statistical Approaches to Genomics , 2007, Springer US.
[2] J. Jónasson,et al. Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival , 1999, British Journal of Cancer.
[3] H. Loiseau,et al. p73 gene transcripts in human brain tumors: overexpression and altered splicing in ependymomas , 1999, Neuroscience Letters.
[4] Chunlei Wu,et al. Alternative Splicing: Genetic Complexity in Cancer , 2003 .
[5] A. Nakagawara,et al. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. , 1998, Cancer Research.
[6] G. Fuller,et al. Genomic and Molecular Neuro-Oncology , 2003 .
[7] J. Bergthórsson,et al. High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer. , 2002, European journal of cancer.
[8] S. Thomson,et al. RT-PCR splicing analysis of the NF1 open reading frame , 2002, Human Genetics.
[9] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[10] E. Goode,et al. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. , 1999, American journal of human genetics.
[11] M. Tschan,et al. Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours , 2000, International journal of cancer.
[12] K. Wakasa,et al. Frequent Loss of Heterozygosity at 1p36.3 and p73 Abnormality in Parathyroid Adenomas , 2001, Modern Pathology.
[13] G. Fuller,et al. Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors. , 2000, Cancer research.
[14] L. Zardi,et al. Transformed human cells release different fibronectin variants than do normal cells , 1986, The Journal of cell biology.
[15] N. L. Thangue,et al. Promoter specificity and stability control of the p53-related protein p73 , 1999, Oncogene.
[16] G. Fuller,et al. IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[17] G. Fuller,et al. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. , 2003, Cancer research.
[18] C. Dani,et al. Extreme instability of myc mRNA in normal and transformed human cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[19] A. Nakagawara,et al. Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells. , 1999, Cancer research.
[20] H. Saya,et al. Germline p53 gene mutations in subsets of glioma patients. , 1994, Journal of the National Cancer Institute.
[21] S. Vicent,et al. αCP-4, Encoded by a Putative Tumor Suppressor Gene at 3p21, But Not Its Alternative Splice Variant αCP-4a, Is Underexpressed in Lung Cancer , 2004, Cancer Research.
[22] B. Scheithauer,et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] J. Bruner,et al. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[24] H. Tsui,et al. SHP-1 variant proteins are absent in motheaten mice despite presence of splice variant transcripts with open reading frames. , 1999, Molecular immunology.
[25] K. Shimotohno,et al. Transcriptional activities of p73 splicing variants are regulated by inter-variant association. , 2001, The Biochemical journal.
[26] M. Berger,et al. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. , 1996, Cancer research.
[27] B. Scheithauer,et al. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype , 1999, Oncogene.
[28] W. Vogel,et al. Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 2. , 2002, Cancer research.
[29] Gudrun Schleiermacher,et al. Gene expression profiling of 1p35–36 genes in neuroblastoma , 2004, Oncogene.
[30] W. Yung,et al. Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. , 1999, Cancer research.
[31] W. V. D. Van de Ven,et al. Calcitonin gene related peptide coding sequence is conserved in the human genome and is expressed in medullary thyroid carcinoma. , 1984, The Journal of clinical endocrinology and metabolism.
[32] O. Kallioniemi,et al. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. , 2000, Cancer research.